Table I.
Parameter/feature | Cohort T (n=348) (%) |
---|---|
Age, years (mean ± SD) | 48.1±15.9 |
Sex | |
Male | 92 (26.4) |
Female | 256 (73.6) |
Race | |
Asian | 46 (13.2) |
Black or African American | 22 (6.3) |
American Indian or | 1 (0.3) |
Alaska native | |
White | 279 (80.2) |
Subtype | |
CPTC | 264 (75.9) |
FPTC | 50 (14.3) |
TCPTC | 34 (9.8) |
Pathologic stage | |
I | 192 (55.2) |
II | 28 (8.0) |
III | 88 (25.3) |
IV | 40 (11.5) |
Tumor size | |
T1 | 105 (30.2) |
T2 | 108 (31.0) |
T3 | 116 (33.3) |
T4 | 17 (4.9) |
TX | 2 (0.6) |
Lymph node | |
N0 | 164 (47.2) |
N1 | 157 (45.2) |
NX | 27 (7.6) |
Metastasis status | |
M0 | 231 (66.4) |
M1 | 6 (1.7) |
MX | 111 (31.9) |
SD, standard deviation; PTC, papillary thyroid cancer; CPTC, classical PTC; FPTC, follicular PTC; TCPTC, tall-cell PTC.